Disappointment and California's Bubble Baby Saga: Some CIRM Directors Look to Avoid a Repetition
$43 million taxpayer investment, trial delayed, two years and counting
For the first time in two years, the directors of the $12 billion California stem cell agency have discussed -- in public -- the case of the “bubble babies” and a stalled treatment that would save the children from their life-threatening affliction.
The discussion lasted o…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.